-+ 0.00%
-+ 0.00%
-+ 0.00%

Kymera Therapeutics Reports Positive Phase 1b Results for Oral STAT6 Degrader KT-621 in Atopic Dermatitis

Reuters·12/08/2025 12:00:13

Please log in to view news